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CytotoxicityAbstract In the present study, a series of 4-(1-aryl-5-chloro-2-oxo-1,2-dihydro-indol-3-ylideneami-
no)-N-substituted benzene sulfonamides (1–20) was synthesized and screened for their in vitro antimi-
crobial activity against Gram positive, Gram negative bacterial and fungal strains indicating that
compound 19 (N-(4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-ylideneamino)phenylsulfonyl)-
4-isopropoxybenzamide) was found to be themost active antimicrobial agent. The anticancer activity
of synthesized compounds against mouse leukemic monocyte macrophage cell line (RAW 264.7) and
colon cancer (HCT116) cell lines indicated that compound 16 (4-(5-Bromo-1-(4-chlorobenzoyl)-2-
oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzene sulfonamide) was found to be
the most potent cytotoxic agent against HCT116 and compounds 17 (4-(5-Bromo-1-(4-chloroben-
zoyl)-2-oxoindolin-3-ylideneamino)-N-(6-methoxypyridazin-3-yl)benzene sulfonamide) and 19
(N-(4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-ylideneamino)phenylsulfonyl)-4-isopropoxyb-
enzamide) were found to be the most potent cytotoxic agents against RAW264.7 cancer cell lines.
ª 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Infectious diseases are the main cause of mortality in the world
and the rapid increase of antimicrobial resistance among path-
ogenic strains (bacterial and fungal) is becoming a serious pub-
lic health problem because microbes replicate very rapidly and
get mutated which help the microbes to survive in the presence
of an antimicrobial drug, these will quickly become predomi-
nant throughout the microbial population. These concerns-indol-
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2 M. Kumar et al.have led to major research efforts to discover new antibacterial
agents that could be used to combat bacterial infections (Amin
et al., 2010).
The development of new anticancer agents is one of the fun-
damental goals in medicinal chemistry. Cytotoxicity and geno-
toxicity of anticancer drugs to the normal cells are major
problems in cancer therapy and engender the risk of inducing
secondary malignancy. Therapeutic dose of almost all antican-
cer drugs is often toxic to the normal tissues and leads to many
side effects, which in turn, limits its treatment efﬁcacy. In
recent years, there has been a concerned search for the discov-
ery and development of novel selective anticancer agents,
devoid of many of the unpleasant side effects of conventional
anticancer agents (Gudipati et al., 2011).
The isatin (1H-indole-2,3-dione) is found as an endogenous
molecule in human and other mammals and its analogs display
diverse types of biological activities including antimicrobial
(Kumar et al., 2012), anticonvulsant (Prakash et al., 2010),
anti-inﬂammatory (Suleyman et al., 2003), anticancer and
anti-HIV (Sriram et al., 2005) activities.
The literature rationale reveals that in particular,
halogenated isatin derivatives have been reported to exhibit
enhanced anticancer activity compared to the parent molecule.
5-Bromo-3-o-nitrophenyl isatin hydrazone and a series of 5-
bromo-(2-oxo-3-indolinyl) thiazolidine-2,4-diones substituted
by various Mannich bases were found to exhibit anticancer
activity against Walker carcinoma-256 and P388 lymphocytic
leukemia in mice, respectively. Moreover, N-benzylation of
5,7-dibromoisatin further increased the cytotoxicity against
U937 (human monocyte-like histiocytic lymphoma) cells and
a range of human cancer cell lines including a metastatic breast
adenocarcinoma cell line (MDA-MB-231). In the recently
approved drugs by FDA, a 5-ﬂuoro-3-substituted-2-oxoindole,
SU11248, is provided for the treatment of gastrointestinal stro-
mal tumors and advanced renal-cell carcinoma (Singh et al.,
2012).
Prompted by the above facts and in continuation of our
efforts in developing novel antimicrobial and cytotoxic agents
(Narang et al., 2012; Judge et al., 2012) we hereby report the
synthesis, antimicrobial and cytotoxic evaluation of 4-(1-aryl-
5-halo-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted
benzenesulfonamides.2. Results and discussion
2.1. Chemistry
The synthesis of 4-(1-aryl-5-halo-2-oxo-1,2-dihydro-indol-3-
ylideneamino)-N-substituted benzenesulfonamides (1–20) was
accomplished by Scheme 1. The physicochemical characteris-
tics of the synthesized compounds are presented in Table 1.
The synthesized compounds were characterized by IR and
1H NMR spectroscopy and the results are in accordance with
the assigned molecular structures. IR stretching band ranging
from 1693–1672 cm1 (C‚O str., ArAC‚O) conﬁrmed the
acylation of isatin. IR stretching band at 1656–1582 cm1
(C‚N str.) conﬁrmed the formation of a Schiff base. In the
1H NMR spectra the signals of the respective protons of the
synthesized compounds were conﬁrmed based on their chemi-
cal shifts and multiplicities. These spectra showed singlets atPlease cite this article in press as: Kumar, M. et al., Synthesis, antimicrobia
3-ylideneamino)-N-substituted benzene sulfonamides. Arabian Journal of3.33–4.76 ppm, which correspond to the SO2NH protons and
multipletes at 7.07–8.52 ppm showed aromatic protons.
2.2. Antimicrobial activity
The antimicrobial activity of the synthesized compounds was
determined by the tube dilution method (Cappucino and
Sherman, 1999) and the results are given in Table 2 which indi-
cated that compound 19 demonstrated potent antibacterial
activity against Staphylococcus aureus (pMICsa = 9.18 lM).
In case of Bacillus subtilis compounds 9 and 16 emerged as
most effective antibacterial agents with pMICbs values of
9.82 and 9.51 lM respectively. Against Gram-negative bacte-
rium Escherichia coli, compounds 19 and 16 (pMICec values
9.18 and 9.51 lM respectively) emerged as most active candi-
dates among the synthesized compounds. In case of antifungal
activity against Candida albicans and Aspergillus niger, com-
pound 19 (pMICca = 4.59 and pMICan values 9.18 lM)
emerged as the most active candidate among the synthesized
compounds. As antifungal activity of compound 19 against
C. albicans (pMICca = 4.59) was greater than standard drug
ﬂuconazole (pMICca = 5.09), it may be taken as a lead mole-
cule for the development of novel antifungal agents.
In general, according to the results of MBC/MFC studies
(Table 3) the synthesized compounds were bacteriostatic and
fungistatic in action as their MFC and MBC values were 3-fold
higher than their MIC values (Emami et al., 2004).
2.3. Cytotoxic activity
The cytotoxic activity of the synthesized isatin derivatives was
determined against mouse leukemic monocyte macrophage
(RAW264.7) and colon cancer (HCT116) cell lines using the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) assay (Mosmann, 1983) and IC50 values (concentration
required to achieve 50 % inhibition of cancer cells) of the stan-
dard and test compounds are presented in Table 1. In general,
most of the synthesized compounds were more active than
standard drug carboplatin (IC50 > 100 lM) against both
HCT116 and RAW264.7 cancer cell lines and none of the syn-
thesized compounds were found to be more active than the
standard drug 5-FU (IC50 = 4.6 and 0.60 lM against
HCT116 and RAW264.7, respectively).
Results of cytotoxic studies indicated that compound 16
(IC50 = 13.7 lM) was found to be the most potent cytotoxic
agent against HCT116 cancer cell line and compounds 17
and 19 (3.19 and 1.47 lM respectively) were found to be most
potent cytotoxic agents against RAW264.7 cancer cell line.
2.3.1. Structure–activity relationship
1. Results of antimicrobial and cytotoxic screening indicated
that 5-bromo isatin derivatives were found to be more
active antimicrobial and cytotoxic agents than 4-chloro
isatin derivatives.
2. Results of antimicrobial study indicated that the presence
of phenyl ring attached to benzenesulfonamide moiety
(19) increased the antimicrobial potential of synthesized
compounds against all the tested microbial strains, except
in case of B. subtilis, against which pyrimidine ring attachedl and cytotoxic evaluation of 4-(1-aryl-5-halo-2-oxo-1,2-dihydro-indol-
Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.009
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Scheme 1 Scheme for the synthesis of 4-(1-aryl-5-halo-2-oxo-1, 2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides
(1–20).
Table 1 Physicochemical characteristics and anticancer activity of the synthesized isatin derivatives.
Comp. M. Pt. (C) M. formula M. Wt. Rf value* % Yield IC50 in lM
HCT116 RAW 264.7
1 220–222 C25H16Cl2N4O5S 555.39 0.62 76 149.44 14.40
2 128–130 C23H15Cl2N3O5S 516.35 0.78 72 153.00 1.94
3 216–218 C25H15Cl2N5O4S 552.39 0.66 60 152.07 14.48
4 248–250 C26H17Cl2N5O4S 566.42 0.84 74 139.47 17.65
5 216–218 C24H14Cl2N4O4S2 557.43 0.74 68 52.02 16.15
6 166–168 C27H19Cl2N5O6S 612.44 0.72 82 99.60 27.76
7 204–206 C26H17Cl2N5O5S 582.41 0.68 85 96.15 15.45
8 196–198 C26H16Cl2N4O5S 551.40 0.74 70 92.49 27.20
9 144–146 C31H23Cl2N3O6S 636.50 0.76 78 98.98 80.13
10 152–154 C22H15Cl2N5O4S 516.36 0.88 80 69.72 40.67
11 112–114 C25H16BrClN4O5S 599.84 0.68 78 140.04 50.01
12 177–179 C23H15BrClN3O5S 560.80 0.68 76 96.29 41.01
13 106–108 C25H15BrClN5O4S 596.84 0.76 82 103.88 16.75
14 188–190 C26H17BrClN5O4S 610.87 0.70 68 83.49 18.01
15 133–135 C24H14BrClN4O4S2 601.98 0.74 78 56.49 11.63
16 173–175 C27H19BrClN5O6S 656.89 0.82 76 13.70 39.58
17 241–243 C26H17BrClN5O5S 626.87 0.68 75 127.62 3.19
18 217–217 C26H16BrClN4O4S 595.85 0.76 80 95.66 35.24
19 211–213 C31H23BrClN3O6S 680.95 0.74 76 45.52 1.47
20 139–141 C22H15BrClN5O4S 560.81 0.82 80 96.29 73.11
Carboplatin >100.00 >100.00
5-Flourouracil 4.60 0.60
* TLC mobile phase = Chloroform:Methanol (7:3).
Synthesis, antimicrobial and cytotoxic evaluation 3to benzenesulfonamide moiety (16) was found to enhance
the antibacterial potential. Further, the presence of electron
releasing groups on pyrimidine/phenyl nucleus improved
the antimicrobial potential of the synthesized compounds.
The role of electron releasing groups in enhancing the anti-
microbial activity of isatin derivatives is supported by study
of Kamal et al. (2010).
3. Results of cytotoxic screening indicated that phenyl
nucleus attached to benzenesulfonamide moiety increased
the cytotoxic potential of the synthesized compounds
against RAW264.7 cancer cell line, whereas itsPlease cite this article in press as: Kumar, M. et al., Synthesis, antimicrobia
3-ylideneamino)-N-substituted benzene sulfonamides. Arabian Journal ofreplacement with pyrimidine nucleus improved the cyto-
toxic potential of the synthesized isatin derivatives against
HCT116 cancer cell line. Further, the presence of electron
releasing groups on pyrimidine/phenyl nucleus improved
the antimicrobial potential of the synthesized compounds.
The role of electron releasing groups in improving cyto-
toxic activity is supported by the studies of Vine et al.
(2007).
4. The presence of electron withdrawing groups, specially 4-Cl
at benzoyl portion improved antimicrobial as well as cyto-
toxic potential of the synthesized isatin derivatives.l and cytotoxic evaluation of 4-(1-aryl-5-halo-2-oxo-1,2-dihydro-indol-
Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.009
Table 2 Antimicrobial activity of synthesized isatin derivatives.
Comp. Minimum inhibitory concentration (MIC, lM)
MICsa MICbs MICec MICca MICan
1 22.51 22.51 11.25 5.63 11.25
2 12.10 12.10 12.10 6.05 12.10
3 11.31 11.31 11.31 5.66 11.31
4 11.03 11.03 11.03 5.52 11.03
5 22.42 22.42 11.21 5.61 11.21
6 20.41 20.41 10.21 5.10 10.21
7 21.46 10.73 10.73 5.37 10.73
8 22.67 11.33 11.33 5.67 11.33
9 9.82 9.82 9.82 4.91 9.82
10 24.21 12.10 12.10 6.05 12.10
11 20.84 20.84 10.42 20.84 10.42
12 11.14 11.14 11.14 22.29 11.14
13 10.47 10.47 10.47 20.94 10.47
14 10.23 10.23 10.23 5.12 10.23
15 10.38 10.38 10.38 5.19 10.38
16 9.51 9.51 9.51 4.76 9.51
17 9.97 9.97 19.94 4.99 9.97
18 10.49 20.98 10.49 5.24 10.49
19 9.18 18.36 9.18 4.59 9.18
20 11.14 22.29 11.14 11.14 11.14
Std. 4.87a 4.87a 4.87a 5.09b 5.09b
a Norﬂoxacin.
b Fluconazole.
Table 3 Minimum bactericidal/fungicidal concentration of synthesized isatin derivatives.
Comp. Minimum bactericidal/fungicidal concentration (MFC/MBC, l mol/ml)
S. aureus B. subtilis E. Coli C. albicans A. niger
1 >0.09 >0.09 >0.09 >0.09 >0.09
2 >0.10 >0.10 >0.10 >0.10 >0.10
3 >0.09 >0.09 >0.09 >0.09 >0.09
4 >0.09 >0.09 >0.09 >0.09 >0.09
5 >0.09 >0.09 >0.09 >0.09 >0.09
6 >0.08 >0.08 >0.08 >0.08 >0.08
7 >0.09 >0.09 >0.09 >0.09 >0.09
8 >0.09 >0.09 >0.09 >0.09 >0.09
9 >0.08 >0.08 >0.08 >0.08 >0.08
10 >0.10 >0.10 >0.10 >0.10 >0.10
11 >0.08 >0.08 >0.08 >0.08 >0.08
12 >0.09 >0.09 >0.09 >0.09 >0.09
13 >0.08 >0.08 >0.08 >0.08 >0.08
14 >0.08 >0.08 >0.08 >0.08 >0.08
15 >0.08 >0.08 >0.08 >0.08 >0.08
16 >0.08 >0.08 >0.08 >0.08 >0.08
17 >0.08 >0.08 >0.08 >0.08 >0.08
18 >0.08 >0.08 >0.08 >0.08 >0.08
19 >0.07 >0.07 >0.07 >0.07 >0.07
20 >0.09 >0.09 >0.09 >0.09 >0.09
Std. 0.0049a 0.0049a 0.0049a 0.0051b 0.0051b
a Norﬂoxacin.
b Fluconazole.
4 M. Kumar et al.5. From the above mentioned antimicrobial and cytotoxic
activity results, it can be concluded that different struc-
tural requirements are necessary for a compound toPlease cite this article in press as: Kumar, M. et al., Synthesis, antimicrobia
3-ylideneamino)-N-substituted benzene sulfonamides. Arabian Journal ofbecome active against different microbial and cancer tar-
gets. This is in accordance with the ﬁndings of Sortino
et al. (2007).l and cytotoxic evaluation of 4-(1-aryl-5-halo-2-oxo-1,2-dihydro-indol-
Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2013.11.009
Synthesis, antimicrobial and cytotoxic evaluation 5The above ﬁndings are summarized in Fig. 1.
3. Experimental
3.1. Chemistry
Starting materials were obtained from commercial sources and
were used without further puriﬁcation. Solvents were dried by
standard procedures. Reaction progress was observed by thin
layer chromatography. Melting points were determined in
open capillary tubes on a Sonar melting point apparatus and
are uncorrected. 1H nuclear magnetic resonance (1H NMR)
spectra were determined by a Bruker 500 MHz NMR spec-
trometer in appropriate deuterated solvents and are expressed
in parts per million (d, ppm) downﬁeld from tetramethylsilane
(internal standard). NMR data are given as multiplicity (s, sin-
glet; d, doublet; t, triplet; m, multiplet) and number of protons.
IR spectra were recorded on a Varian Resolutions Pro spectro-
photometer in a KBr disk.
3.2. General procedure for the synthesis of 4-(1-Aryl-5-halo-2-
oxo-1, 2-dihydro-indol-3-ylideneamino)-N-Substituted
benzenesulfonamides (1–20)
Thionyl chloride 32.8 g (0.3 mol) was added to different aro-
matic acids (0.25 mol) in a round bottom ﬂask. After addition,
the mixture was reﬂuxed for 1 h and 30 min. The excess of
thionyl chloride was removed by distillation. To the solution
of acyl chloride (1 mol, synthesized in previous step), was
added 0.1 mol of haloisatin and the mixture was reﬂuxed for
1 h. Then the reaction mixture was cooled and the resultant
precipitate (N-acyl haloisatin) was collected, washed with hex-
ane and recrystallized from ethyl acetate. A solution of
0.05 mol of different sulfonamides in warm ethanol was added
to the solution of corresponding N-acyl haloisatins (0.05 mol)
in the presence of small amount of glacial acetic acid. The mix-
ture was reﬂuxed for 4–5 h. Then the reaction mixture was
allowed to cool at room temperature and the precipitate
obtained was ﬁltered, dried and recrystallized from ethanol.
3.2.1. 4-(5-Chloro-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(5-methyl Isoxazol-3-yl)benzenesulfonamide
(1)
IR (KBr pellets) cm1: 1515 (NH in plane bending, sec.
amine), 1691 (C‚O str., ArAC‚O), 1656 (C‚N str.), 1176N
O
C
N S
O
O
NH
O
R
Ar
O
N
N
R
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Figure 1 Structure–activity relationship for antimicrobial
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str., ArACl), 838 (CH out of plane bending, isoxazole), 673
(CH out of plane bending, indole); 1H NMR (DMSO) d:
7.28–8.03 (m, 12H, ArH), 4.27 (s, 1H, SO2NH), 2.29 (s, 3H,
ArCH3).
3.2.2. N-(4-(5-Chloro-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino) phenylsulfonyl)acetamide (2)
IR (KBr pellets) cm1: 1515 (NH in plane bending, sec.
amine), 1691 (C‚O str., ArAC‚O), 1655 (C‚N str.), 1177
(O‚S‚O str.), 1434 (CH3 bending vibration, COCH3), 786
(CACl str., ArACl), 674 (CH out of plane bending, indole);
1H NMR (DMSO) d: 7.51–8.51 (m, 12H, ArH), 4.27 (s, 1H,
SO2NH), 2.50 (s, 3H, COCH3).
3.2.3. 4-(5-Chloro-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(pyrimidin-2-yl) benzenesulfonamide (3)
IR (KBr pellets) cm1: 1495 (NH in plane bending, sec.
amine), 1682 (C‚O str., ArAC‚O), 1648 (C‚N str.), 1157
(O‚S‚O str.), 1582 (C‚N str., pyrimidine), 786 (CACl
str., ArACl), 731 (CH out of plane bending, 4-sustituted
pyrimidine), 674 (CH out of plane bending, indole); 1H
NMR (DMSO) d: 7.07–8.52 (m, 15H, ArH), 4.27 (s, 1H,
SO2NH).
3.2.4. 4-(5-Chloro-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(4-methyl pyrimidin-2-yl)benzenesulfonamide
(4)
IR (KBr pellets) cm1: 1515 (NH in plane bending, sec.
amine), 1691 (C‚O str., ArAC‚O), 1656 (C‚N str), 1177
(O‚S‚O str), 1583 (C‚N str., pyridine), 786 (CACl str.,
ArACl), 880 (CH out of plane bending, 4-sustituted pyrimi-
dine), 674 (CH out of plane bending, indole); 1H NMR
(DMSO) d: 7.50–7.73 (m, 14H, ArH), 4.27 (s, 1H, SO2NH),
2.51 (s, 3H, ArCH3).
3.2.5. 4-(5-Chloro-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(thiazol-2-yl) benzenesulfonamide (5)
IR (KBr pellets) cm1: 1511 (NH in plane bending, sec.
amine), 1693 (C‚O str., ArAC‚O), 1650 (C‚N str.), 1181
(O‚S‚O str.), 1578 (C‚N str., thiazole), 782 (CACl str.,
ArACl), 733 (C–S–C str., thiazole), 893 (CH out of plane
bending, thiazole), 629 (CH out of plane bending, indole);
1H NMR (DMSO) d: 6.75–7.87 (m, 14, ArH), 4.27 (s, 1H,
SO2NH).R
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and anticancer activity of synthesized isatin derivatives.
l and cytotoxic evaluation of 4-(1-aryl-5-halo-2-oxo-1,2-dihydro-indol-
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6 M. Kumar et al.3.2.6. 4-(5-Chloro-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(4,6-dimethylpyrimidin-2-
yl)benzenesulfonamide (6)
IR (KBr pellets) cm1: 1516 (NH in plane bending, sec. amine),
1692 (C‚O str., ArAC‚O), 1656 (C‚N str.), 1178 (O‚S‚O
str.), 1290 (C–OC str.), 1583 (C‚N str., pyrimidine), 1609
(C‚C str., pyrimidine), 786 (CACl str., ArACl), 669 (CH
out of plane bending, indole); 1H NMR (DMSO) d: 7.51–7.72
(m, 13H, ArH), 4.27 (s, 1H, SO2NH), 2.31 (s, 6H, ArCH3).
3.2.7. 4-(5-Chloro-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(6-methoxy pyridazin-3-
yl)benzenesulfonamide (7)
IR (KBr pellets) cm1: 1516 (NH in plane bending, sec.
amine), 1691 (C‚O str., ArAC‚O), 1658 (C‚N str.), 1180
(O‚S‚O str.), 1292 (C–O–C str.), 1471 (N–N str., pyrida-
zine), 788 (CACl str., ArACl), 672 (CH out of plane bending,
indole); 1H NMR (DMSO) d: 7.51–7.73 (m, 14H, ArH), 4.29
(s, 1H, SO2NH), 3.35 (s, 3H, ArOCH3).
3.2.8. 4-(5-Chloro-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(pyridin-2-yl)ibenzenesulfonamide (8)
IR (KBr pellets) cm1: 1516 (NH in plane bending, sec.
amine), 1691 (C‚O str., ArAC‚O), 1658 (C‚N str.), 1181
(O‚S‚O str.), 1583 (C‚N str., pyridine), 1607 (C‚C str.,
pyridine), 785 (CACl str., ArACl), 673 (CH out of plane bend-
ing, indole); 1H NMR (DMSO) d: 7.37–7.73 (m, 16H, ArH),
4.27 (s, 1H, SO2NH).
3.2.9. N-(4-(5-Chloro-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)phenylsulfonyl)-4-isopropoxybenzamide (9)
IR (KBr pellets) cm1: 1507 (NH in plane bending, sec.
amine), 1691 (C‚O str., ArAC‚O), 1653 (C‚N str.), 1182
(O‚S‚O str.), 1165 (CH(CH3)2 bending), 1260 (C–O–C
str.), 783 (CACl str., ArACl), 677 (CH out of plane bending,
indole); 1H NMR (DMSO) d: 7.50–7.82 (m,16H, ArH), 4.72
(s, 1H, SO2NH), 4.27 (s, 1H, CH), 1.28 (d, 6H, CH(CH3)2)
3.2.10. 1-(4-(5-Chloro-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)phenylsulfonyl)guanidine (10)
IR (KBr pellets) cm1: 1513 (NH in plane bending, sec.
amine), 1690 (C‚O str., ArAC‚O), 1655 (C‚N str.), 1177
(O‚S‚O str.), 785 (CACl str., ArACl), 670 (CH out of plane
bending, indole); 1H NMR (DMSO) d: 7.53–7.94 (m, 12H,
ArH), 4.30 (s, 1H, SO2NH), 3.31 (s, 3H, COCH3).
3.2.11. 4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(5-methyl isoxazol-3-yl)benzenesulfonamide
(11)
IR (KBr pellets) cm1: 1517 (NH in plane bending, sec.
amine), 1678 (C‚O str., ArAC‚O), 1620 (C‚N str.), 1166
(O‚S‚O str.), 545 (CABr str., ArABr), 814 (CH out of plane
bending, isoxazole), 628 (CH out of plane bending, indole); 1H
NMR (DMSO) d: 7.46–7.95 (m, 12H, ArH), 4.27 (s, 1H,
SO2NH), 2.28 (s, 3H, ArCH3).
3.2.12. N-(4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)phenylsulfonyl) acetamide (12)
IR (KBr pellets) cm1: 1491 (NH in plane bending, sec.
amine), 1678 (C‚O str., ArAC‚O), 1588 (C‚N str.), 1174Please cite this article in press as: Kumar, M. et al., Synthesis, antimicrobia
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vibration, COCH3), 628 (CH out of plane bending, indole);
1H NMR (DMSO) d: 7.39–7.96 (m, 14H, ArH), 4.27 (s, 1H,
SO2NH), 2.37 (s, 3H, COCH3).
3.2.13. 4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(pyrimidin-2-yl) benzenesulfonamide (13)
IR (KBr pellets) cm1: 1490 (NH in plane bending, sec.
amine), 1677 (C‚O str., ArAC‚O), 1587 (C‚N str.), 1158
(O‚S‚O str.), 544 (CABr str., ArABr), 1610 (C‚N
str.,pyrimidine), 758 (CH out of plane bending, 4-sustituted
pyrimidine), 630 (CH out of plane bending, indole); 1H
NMR (DMSO) d: 7.56–8.51 (m, 14H, ArH), 3.35 (s, 1H,
SO2NH).
3.2.14. 4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(4-methyl pyrimidin-2-yl)benzenesulfonamide
(14)
IR (KBr pellets) cm1: 1492 (NH in plane bending, sec.
amine), 1678 (C‚O str., ArAC‚O), 1589 (C‚N str.), 1173
(O‚S‚O str.), 544 (CABr str., ArABr), 1608 (C‚N str.,
pyrimidine), 759 (CH out of plane bending, 4-sustituted pyrim-
idine), 628 (CH out of plane bending, indole); 1H NMR
(DMSO) d: 7.93–8.33 (m, 13H, ArH), 3.33 (s, 1H, SO2NH),
2.33 (s, 3H, ArCH3).
3.2.15. 4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(thiazol-2-yl)ibenzenesulfonamide (15)
IR (KBr pellets) cm1: 1490 (NH in plane bending, sec.
amine), 1672 (C‚O str., ArAC‚O), 1589 (C‚N str.), 1149
(O‚S‚O str.), 538 (CABr str., ArABr), 1570 (C‚N str., thi-
azole), 742 (C–S–C str., thiazole), 894–636 (CH out of plane
bending, thiazole), 667 (CH out of plane bending, indole);
1H NMR (DMSO) d: 7.56–8.00 (m, 13, ArH), 3.32 (s, 1H,
SO2NH).
3.2.16. 4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(4,6-dimethylipyrimidin-2-
yl)benzenesulfonamide (16)
IR (KBr pellets) cm1: 1493 (NH in plane bending, sec.
amine), 1676 (C‚O str., ArAC‚O), 1590 (C‚N str.), 1155
(O‚S‚O str.), 544 (CABr str., ArABr), 1281 (C–O–C str.),
614 (CH out of plane bending, indole); 1H NMR (DMSO) d:
7.58–7.94 (m, 12H, ArH), 3.28 (s, 1H, SO2NH), 2.57 (s, 6H,
ArCH3).
3.2.17. 4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(6-methoxyipyridazin-3-
yl)benzenesulfonamide (17)
IR (KBr pellets) cm1: 1524 (NH in plane bending, sec.
amine), 1677 (C‚O str., ArAC‚O), 1588 (C‚N str.), 1181
(O‚S‚O str.), 1278 (C–O–C str.), 1470 (N–N str., pyrida-
zine), 546 (CABr str., ArABr), 616 (CH out of plane bending,
indole); 1H NMR (DMSO) d: 7.33–7.96 (m, 13H, ArH), 4.08
(s, 1H, SO2NH), 3.34 (s, 3H, ArOCH3).
3.2.18. 4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)-N-(pyridin-2-yl)ibenzenesulfonamide (18)
IR (KBr pellets) cm1: 1493 (NH in plane bending, sec.
amine), 1679 (C‚O str., ArAC‚O), 1631 (C‚N str.), 1174l and cytotoxic evaluation of 4-(1-aryl-5-halo-2-oxo-1,2-dihydro-indol-
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idine), 614 (CH out of plane bending, indole); 1H NMR
(DMSO) d: 7.16–8.03 (m, 15H, ArH), 3.33 (s, 1H, SO2NH).
3.2.19. N-(4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)phenylsulfonyl)-4-isopropoxybenzamide (19)
IR (KBr pellets) cm1: 1522 (NH in plane bending, sec.
amine), 1679 (C‚O str., ArAC‚O), 1661 (C‚N str.), 1178
(O‚S‚O str.), 1133(CH(CH3)2 bending), 1284 (C–O–C
str.), 542 (CABr str., ArABr), 618 (CH out of plane bending,
indole); 1H NMR (DMSO) d: 7.56–8.01 (m, 15H, ArH), 3.32
(s, 1H, SO2NH), 2.64 (s, 1H, CH), 1.25 (d, 6H, CH(CH3)2).
3.2.20. 1-(4-(5-Bromo-1-(4-chlorobenzoyl)-2-oxoindolin-3-
ylideneamino)phenylsulfonyl)guanidine (20)
IR (KBr pellets) cm1: 1498 (NH in plane bending, sec.
amine), 1678 (C‚O str., ArAC‚O), 1627 (C‚N str.), 1164
(O‚S‚O str.), 549 (CABr str., ArABr), 643 (CH out of plane
bending, indole); 1H NMR (DMSO) d: 7.57–7.96 (m, 11H,
ArH), 4.73 (s, 1H, SO2NH), 3.30 (s, 3H, COCH3).
3.3. Evaluation of antimicrobial activity
3.3.1. Determination of MIC
The antimicrobial activity was performed against Gram-posi-
tive bacteria: S. aureus, B. subtilis, the Gram-negative bacte-
rium E. coli and fungal strains: C. albicans and A. niger
using the tube dilution method (Cappucino and Sherman,
1999). Dilutions of test and standard compounds were pre-
pared in double strength nutrient broth – I.P. (bacteria) or
Sabouraud dextrose broth – I.P. (fungi) (Pharmacopoeia of
India, 2007). The samples were incubated at 37 C for 24 h
(bacteria), at 25 C for 7 d (A. niger) and at 37 C for 48 h
(C. albicans) and the results were recorded in terms of mini-
mum inhibitory concentration (MIC).
3.3.2. Determination of MBC/MFC
The minimum bactericidal concentration (MBC) and mini-
mum fungicidal concentration (MFC) were determined by
sub culturing 100 lL of culture from each tube (which
remained clear in the MIC determination) on fresh medium.
MBC and MFC values represent the lowest concentration of
compound that produces a 99.9% end point reduction
(Rodriguez-Arguelles et al., 2005).
3.3.3. Cytotoxic studies
The cytotoxic activity of the synthesized 4-(1-aryl-5-halo-2-
oxo-1, 2-dihydro-indol-3-ylideneamino)-N-substituted ben-
zenesulfonamides was determined against mouse leukemic
monocyte macrophage (RAW264.7) and colon cancer
(HCT116) cell lines. Cancer cell lines were purchased from
the American Type Culture Collection (ATCC), Manassas,
VA, USA. All cell lines were cultured in RPMI 1640 (Sigma)
supplemented with 10% heat inactivated fetal bovine serum
(FBS) (PAA Laboratories) and 1% penicillin/streptomycin
(PAA Laboratories). Cultures were maintained in a humidiﬁed
incubator at 37 C in an atmosphere of 5% CO2. Cytotoxicity
of the synthesized compounds at various concentrations was
assessed using the 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl
tetrazolium bromide (MTT) (Sigma) assay, as described byPlease cite this article in press as: Kumar, M. et al., Synthesis, antimicrobia
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lowing 72 h of incubation. Assay plates were read using a spec-
trophotometer at 520 nm. Data generated were used to plot a
dose–response curve of which the concentration of test com-
pounds required to kill 50% of the cell population (IC50)
was determined. Cytotoxic activity was expressed as the mean
IC50 of three independent experiments.
4. Conclusion
A series of 4-(1-aryl-5-halo-2-oxo-1,2-dihydro-indol-3-ylide-
neamino)-N-substituted benzenesulfonamide derivatives
(1–20) was synthesized in appreciable yield and characterized
by physicochemical as well as spectral means. The synthesized
compounds were evaluated for their in vitro antimicrobial and
cytotoxic activities. Results of antimicrobial study indicated
that the presence of phenyl ring attached to benzene sulfon-
amide moiety 19 increased the antimicrobial potential of
synthesized compounds against all the tested microbial strains.
Further, the presence of electron releasing groups on pyrimi-
dine/phenyl nucleus improved the antimicrobial potential of
the synthesized compounds. As antifungal activity of com-
pound 19 against C. albicans (pMICca = 4.59) was greater
than standard drug ﬂuconazole (pMICca = 5.09), it may be
taken as a lead molecule for the development of novel anti-
fungal agents. Cytotoxic activity results indicated that most
of the synthesized compounds were more active than the stan-
dard drug carboplatin against both the cancer cell lines
(HCT116 and RAW264.7) but less active than the standard
drug 5-FU. Compound 16 was found to be the most potent
cytotoxic agent against HCT116 and compounds 17 and 19
were found to be most potent cytotoxic agents against
RAW264.7 cancer cell lines. In general the presence of elcec-
tron withdrawing groups, especially 4-Cl at benzoyl portion
improved antimicrobial as well as cytotoxic potential of the
synthesized isatin derivatives.
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